Free Trial
→ Turn $1K into $50K with This DeFi Gem (From Crypto 101 Media) (Ad)tc pixel Free CPRX Stock Alerts

Catalyst Pharmaceuticals (CPRX) SEC Filings & 10K Form

Catalyst Pharmaceuticals logo
$20.59 +0.21 (+1.03%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$20.43 -0.16 (-0.78%)
As of 08/29/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Catalyst Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/28/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K/A
08/27/2025
3:14 PM		Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
12:07 PM		Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
9:46 AM		Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Curran Daniel J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2025
3:31 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
2:42 PM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
1:44 PM		Catalyst Pharmaceuticals (Subject)
O'Keeffe Charles B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
9:45 AM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:14 AM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2025
11:32 AM		BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
4:19 PM		Catalyst Pharmaceuticals (Filer)
Form ARS
04/09/2025
7:55 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:09 PM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:21 PM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
9:21 AM		Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:40 PM		Catalyst Pharmaceuticals (Issuer)
Russo Gregg (Reporting)
Form 3/A
02/26/2025
3:37 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:05 PM		Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
7:57 AM		Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SCHEDULE 13G/A
01/24/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:07 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:24 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad)

Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel

Click here for the full story.
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
11:55 AM		Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:08 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
1:42 PM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
8:42 AM		Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
11:37 AM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:11 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
1:57 PM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:55 AM		Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
11/13/2024
4:44 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:52 AM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:10 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:08 PM		Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
2:31 PM		BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
10/17/2024
11:14 AM		Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/26/2024
7:42 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CPRX) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...
Brownstone Research | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...
Crypto 101 Media | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
An MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...
True Market Insiders | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel